Hodgkin's lymphoma Posts Page 2 on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

Total lymphoid irradiation as part of a salvage regimen for patients with unresponsive Hodgkin Lymphoma

Posted by on Apr 9, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors looked at the long-term results of total lymphoid irradiation for patients with relapsed or unresponsive Hodgkin lymphoma. The authors concluded that total lymphoid irradiation combined with high-dose chemotherapy is a safe and effective treatment for patients with relapsed or unresponsive Hodgkin lymphoma. Some background...

Read More

Accuracy of FDG-PET at classifying patients as in remission: A systematic review

Posted by on Mar 26, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This review looked at the ability of F-luoro-2-deoxy-D-glucose positron emission topography (FDG-PET) to predict complete disease remission in patients with Hodgkin lymphoma who have completed first-line treatment. The authors suggested that FDG-PET may not be fully accurate at predicting remission in patients who have completed...

Read More

Outcomes of donor stem cell transplantation improving for relapsed Hodgkin lymphoma patients

Posted by on Mar 25, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined the outcomes of allogenic (donor) stem cell transplantation in two different time periods. The authors found that those treated in the later time period, 2009-2013, had better overall survival and fewer relapses, largely due to improvements in treatment options. Some background Hodgkin lymphoma is widely...

Read More

Haploidentical stem cell transplantation: Treatment option for patients with refractory or relapsed Hodgkin Lymphoma

Posted by on Mar 11, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined a treatment for advanced Hodgkin lymphoma, haploidentical stem cell transplantation with post-infusion cyclophosphamide (haplo-HSCT). The authors concluded that the use of haplo-HSCT is a valid treatment option for patients with advanced Hodgkin lymphoma (HL).  Some background Hodgkin lymphoma is...

Read More

What is the role of combined chemotherapy and radiation in early-stage Hodgkin lymphoma?

Posted by on Mar 11, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study explored whether radiation therapy was necessary in patients with early-stage Hodgkin lymphoma. The study concluded that disease progression occurred more often in patients who did not undergo radiation. Some background The standard treatment option for early stage Hodgkin lymphoma is chemotherapy followed by radiation....

Read More

Comparing pre-stem cell transplantation chemotherapy: myeloblative vs reduced-intensity conditioning therapy

Posted by on Mar 4, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors compared two different intensities of chemotherapy regimens for use before allogenic stem cell transplantation. The authors suggested that the two treatments had similar patient outcomes, with more intense therapy having slightly better outcomes.  Some background Hodgkin lymphoma (HL) is considered a curable disease....

Read More

Nodular lymphocyte predominant Hodgkin lymphoma: Types of treatment and clinical outcomes

Posted by on Mar 2, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell The authors looked at patient characteristics, types of treatment, and clinical outcomes for patients with nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). The study confirmed the positive long-term outcome of this disease.  The authors suggested that it may be possible to reduce the intensity of the treatment without...

Read More